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Available online 5 September 2013Abstract Notch signalling has been implicated during haematopoietic development in vivo and in the differentiation of
haematopoietic cells from pluripotent cells in vitro. However interpretation of data from many of these studies has been
complicated by the heterogeneous nature of cell populations under study and by the fact that the Notch pathway is active
during embryogenesis prior to the development of the haematopoietic system. To define the role of Notch signalling in more
precise cell populations during the early stages of haematopoietic development within the aorta–gonad–mesonephros (AGM)
microenvironment we co-cultured differentiating ESCs on a stromal cell line derived from this region of the embryo. Our
co-culture system had no effect on the production of FLK1+ mesoderm progenitor cells but promoted their subsequent
haematopoietic differentiation. We assessed the role of Notch signalling on haematopoietic differentiation of isolated FLK1+
cells. Notch activity is dynamic and drops to basal levels as FLK1+ cells commit to a haematopoietic fate. Further reduction of
Notch activity by the inducible expression of dominant negative MAML had no functional consequences. In contrast, induction
of Notch activity using an inducible NotchIC expression system had an inhibitory effect on haematopoietic differentiation. We
used a Cre-mediated recombination strategy whereby NotchIC-expressing cells were marked with the hCD2 receptor and
observed a reduction in the number of multi-lineage and myeloid colonies derived from NotchIC+ compared to NotchIC− FLK1+
cells isolated from the same culture. We believe that our culture system represents a good model for haematopoietic
development within the AGM microenvironment and our data suggest that haematopoietic commitment of FLK1+ cells in this
setting occurs when Notch activity is below a specific threshold.
© 2013 Elsevier B.V. All rights reserved.Introduction
Directed differentiation of pluripotent cells into haema-
topoietic lineages has been widely used as a tool to study the
molecular mechanisms involved in haematopoietic develop-⁎ Corresponding author. Fax: +44 131 651 9501.
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http://dx.doi.org/10.1016/j.scr.2013.08.012ment as well as a potential source of cells for regenerative
therapies (Kolios and Moodley, 2013; Okano et al., 2013).
However, there are significant challenges facing the produc-
tion of therapeutic cell populations from these sources. It has
not been possible to produce haematopoietic stem cells (HSCs)
capable of long-term reconstitution from human embryonic
stem cells (ESCs) or induced pluripotent stem cells (iPSC) and
differentiated cell types that have been generated tend to
display immature phenotypes. ESC-derived erythrocytes, for
1274 C. Huang et al.example, are incapable of undertaking the final enucleation
step in their maturation and do not switch on the appropriate
adult globin genes (Dias et al., 2011; Lapillonne et al., 2010;
Mountford et al., 2010). Some of these problems have been
partly resolved by co-culturing differentiating ESCs on stromal
cell lines derived from various sites of haematopoietic activity
in vivo such as bone marrow, foetal liver or the aorta–gonad–
mesonephros (AGM) region. This highlights the importance of
appropriate signals from the haematopoietic niche. A fuller
understanding of the molecular mechanisms associated with
haematopoietic niche in vivo and in co-culture systems in vitro
is an essential step towards the development of robust dif-
ferentiation protocols that can be translated into the clinic.
Murine haematopoiesis first occurs in the extra-embryonic
yolk sac around embryonic day 7.5 with the formation of blood
islands containing primitive erythrocytes surrounded by devel-
oping endothelial cells (Ferkowicz and Yoder, 2005; Moore and
Metcalf, 1970; Palis et al., 1999; Palis and Yoder, 2001). This
transient wave of haematopoiesis is followed by the permanent
“definitive” process where multi-potential HSCs and haema-
topoietic progenitor cells (HPCs) appear in several anatomical
sites (Cumano et al., 1996; Godin et al., 1995; Muller et al.,
1994; Ottersbach and Dzierzak, 2005; Palis et al., 1999; Yoder
et al., 1997). HSCs first arise de novo in the AGM region at E10.5
indicating that this region is a potent source of haema-
topoietic inducing signals (Kumaravelu et al., 2002; Medvinsky
and Dzierzak, 1996; Medvinsky et al., 1993, 1996,). Indeed a
number of studies, including our own, have demonstrated that
signals from primary AGM tissue and/or stromal cells derived
thereof can promote the haematopoietic differentiation of both
mouse and human pluripotent cells (Krassowska et al., 2006;
Ledran et al., 2008; Matsuoka et al., 2001; Ohneda et al., 1998;
Oostendorp et al., 2002a,b;Weisel et al., 2006; Xu et al., 1998).
One of these cell lines derived from the aorta and surrounding
mesenchyme (AM) also promoted the production of cells
capable of limited engraftment in the peripheral blood from
human ESCs in vivo (Ledran et al., 2008). We demonstrated
previously that one of the haematopoietic-promoting cell lines
derived from the AM region exerted its effects after the
formation of T/Bry+ mesoderm. Our finding that cell–cell
contact was required for the promoting activity and that this
was partially inhibited by the gamma secretase inhibitor (GSI) is
consistent with the idea that the Notch pathway could be
involved in this process (Gordon-Keylock et al., 2010). In this
study we assessed the effects of the AM microenvironment on
the production of FLK1+ mesoderm progenitor cells and the role
of the Notch pathway on the further differentiation of FLK1+
cells into haematopoietic lineages.
The Notch signalling pathway has been implicated as an
important regulator of haematopoietic development (Bigas
and Espinosa, 2012). Four Notch receptors (Notch1–4) and
five ligands (Delta-like 1, 3, & 4 and Jagged 1 & 2) have been
identified in vertebrates. The transduction of Notch signalling
requires a series of processes including receptor proteolytic
cleavage producing the intracellular component, NotchIC,
recruitment of mastermind-like protein (MAML), p300 to form
RBP-Jκ activator complex and ultimately the activation of
downstream genes including members of the Hes/Hey families
andGata2 (Lai, 2004; Robert-Moreno et al., 2005;Weng et al.,
2003).
Both gain and loss of function studies have demonstrated
a critical role for Notch signalling during haematopoieticdevelopment in vivo and during ESC differentiation in vitro.
Several studies have suggested a differential effect of
Notch signalling on the primitive and definitive wave of
haematopoietic development (Bigas and Espinosa, 2012). For
example ectopic Notch1 has been reported to have an inhibitory
effect on the haematopoietic differentiation of ESCs and on the
expansion or survival of HPCs cultured on OP9 stromal cells
(Schroeder et al., 2006) (Ganapati et al., 2007) and loss of
function studies using Notch1 deficient ESCs indicated that
Notch signalling was dispensable for primitive but not definitive
haematopoiesis (Cheng et al., 2008; Hadland, 2004). More
recently activation of Notch signalling in differentiating human
ESCs enhanced the generation of haematopoietic cells from
committed progenitors (Yu et al., 2008). However, most of
these experiments have been performed using heterogeneous
cell populations so it is not clear precisely when during the
differentiation that Notch signals are active and it is difficult to
define the precise cell–cell interactions that are responsible
for any phenotypic effects. In ESC systems the fact that ectopic
NotchIC inhibited the differentiation of mesoderm and the
inherent problems associated with clonal variation between
ESC lines have further complicated the interpretation on
haematopoietic commitment (Schroeder et al., 2003a, 2006).
To assess the involvement of Notch signalling on defined
cell populations within the AGM microenvironment we es-
tablished a novel system whereby we co-cultured isolated
FLK1+ cells on AGM-derived stromal cell lines. We used
inducible expression of either NotchIC or dominant negative
MAML as gain- and loss-of-function strategies respectively to
manipulate Notch activity within this defined cell population
at specific time points during differentiation. Potential
problems associated with transgene silencing during differ-
entiation have been avoided by targeting our inducible
constructs into the permissive Rosa26 and Hprt loci. The
Cre-mediated recombination strategy that we have used to
express NotchIC allows us to compare directly NotchIC+ and
NotchIC− cells from the same culture, avoiding clonal
variability between ESC subclones (Schroeder et al.,
2003a). Using this elegant system we have been able to
dissect precisely the role of Notch signalling on the specifica-
tion of haematopoietic cells from Flk1+ precursors within the
AGM microenvironment, uncovering an inhibitory effect of
Notch signalling on haematopoietic commitment.Materials and methods
Cell maintenance
ESC lines that were used in this study included control wild type
E14IV; control wild type, constitutively expressing, 7a-GFP
(Gilchrist et al., 2003); the parental A2lox.Cre (Iacovino et al.,
2011); a tamoxifen-inducible NotchIC, NIC-C5 (Lowell et al.,
2006); doxycycline (dox)-inducible dominant negative MAML,
iDML.1 (see below) and a dox-inducible EGFP, iEGFP.1. All ESC
lines were maintained in their undifferentiated state as
described previously (Gordon-Keylock et al., 2010; Krassowska
et al., 2006). The AM stromal cell line (AM14/AM14.1C4) was
derived from the aorta and surrounding mesenchyme of E11
AGM tissue (Oostendorp et al., 2002a,b) and maintained on
gelatinized flasks in medium as described (Gordon-Keylock et
al., 2010; Krassowska et al., 2006).
Figure 1 Co-culture on AM14 stromal cells does not affect the production of FLK1+ cells but promotes their subsequent haematopoietic
differentiation. A. Schematic of experimental strategy: Day 1 EBs were co-cultured on AM14 stromal cells or gelatin control. Cells were
harvested and sorted from stromal cells at days 3, 4, and 5 and FLK1 expression kinetics was assessed by flow cytometry and qRT-PCR.
B. Kinetics of Flk1 mRNA assessed by qRT-PCR in EBs sorted from co-cultures on gelatin or AM14 stromal cells. 18s was used as the internal
control and the calibrator (day 1EB RNA) was assigned a value of 1. C. Kinetics of production of FLK1+ cells assessed by flow cytometry in EBs
cultured on gelatin or AM14 stromal cells. D. Schematic of experimental strategy: FLK1+ cells were magnetically sorted from differentiating
day 4 EBs, co-cultured on AM14 stromal cells or gelatin control for a further 2 days (day 6) then analysed by flow cytometry and in vitro colony
forming assays. E. The number of CFU-C (per 105 cells) was approximately 3-fold higher in FLK1+ cells derived from two independent ESC lines
(E14IV and NIC-C5) that were cultured on AM14 stromal cells compared to gelatin controls. F. Percentage of haematopoietic progenitors
(defined by co-expression of CD41 and cKit) produced from isolated FLK1+ cells derived from E14IV and NIC-C5 day 4EBs was significantly
higher in AM14 co-cultures compared to gelatin control. This was assessed as both % and total number of CD41+cKit+ cells. Data in B and C
represent the mean of 3 independent experiments; error bars represent SEM. Data in E–F represent the mean of 6–7 independent
experiments; error bars represent SEM; P-values calculated using Mann–Whitney test or Wilcoxon signed rank test (*p b 0.05).
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Figure 2 AM14 and OP9 stromal cell lines have a distinct profile of Notch ligand expression. A. q-RT-PCR of Jag1, Jag2, Dll1 and Dll4
in AM14 and OP9 stromal cells. AM14 stromal cells expressed significant lower Jag1 but higher Jag2 compared to OP9. No significant
difference was observed in the expression of Dll1 or Dll4 between the two cell lines was observed. B. Flow cytometry analysis of Jag1
and Dll1 in AM14 and OP9 stromal cells. A significant higher proportion of OP9 cells expressed Jag1 compared to AM14, whereas a
similar proportion of Dll1 positive cells were observed in the two cell lines. C. Immunohistochemistry analysis of Dll4 expression
(green) in AM14 and OP9 cell lines. Nuclei are stained with DAPI (blue). Data in A represent the mean of 2 or 3 independent
experiments; error bars represent SEM. Data in B represent the mean of 4 independent experiments; error bars represent SEM.
P-values calculated using Mann–Whitney test or Wilcoxon signed rank test (*p b 0.05, *** p b 0.001).
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Figure 3 Ectopic NotchIC abrogates haematopoietic differentiation of FLK1+ cells in the AM14 co-culture system. A. Schematic of
experimental strategy: FLK1+ cells were magnetically sorted from differentiating day 4 EBs, co-cultured on AM14 stromal cells in the
presence or absence of 4-OHT for a further 2 days then analysed by flow cytometry, qRT-PCR and in vitro colony forming assays.
B. The frequency of CD41+/cKit+ haematopoietic progenitors was significantly decreased when the expression of NotchIC was induced
by addition of 4-OHT in FLK1+ cells derived from the NIC-C5 cell line. 4-OHT had no significant effect on the percentage of progenitors
derived from control E14 IV cells. Data represent 7 independent experiments; error bars represented SEM. P value was calculated
with Wilcoxon matched pairs test. (**p b 0.01). C–E. The number of myelo-erythroid colonies (C) and myeloid colonies (D) but not
erythroid colonies (E) was significantly reduced when the expression of NotchIC was induced upon addition of 4-OHT to FLK1+ cells
derived from the NIC-C5 cell line during co-culture with AM14 stromal cells. 4-OHT had no significant effect on the number of colonies
generated from control E14 IV cells. All CFU-C results are expressed as number per 105 cells). Data represent 7 independent
experiments; error bars, SEM. P values were calculated with Wilcoxon matched pairs test. (**p b 0.01).
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A MAML peptide fused to GFP (DML-GFP) has been shown
previously to act in a dominant negative manner (Weng et al.,
2003). This DML-EGFP cDNA was excised (BglII (blunted)/NotI)
frompEGFP-DML-N3 plasmid (Weng et al., 2003) and cloned into
the p2lox (XhoI (blunted)/NotI) (Iacovino et al., 2011).
A2lox.Cre ESCs (Iacovino et al., 2011) were passaged twice
then treated with 1 μg/ml dox for 24 h to induce CRE
recombinase expression before electroporation. ESC (0.77 ml
of 107/ml) were electroporated with 30 μg (1 μg/μl) of the
p2lox.DML-EGFP or p2lox.EGFP plasmid using a BIORAD gene
pulser electroporator then selected in 270 ng/ml G418
(Geneticin) for 9 days. Single ESC clones were picked and
expanded for further validation.
Haematopoietic differentiation
Embryoid bodies (EBs) were formed in hanging drops in the
presence of leukaemia inhibitory factor (LIF) for 2 days,
placed in suspension culture for 1 day in the absence of LIFthen co-cultured on confluent γ-irradiated (40 Gy) stromal
cell layers or gelatinized flasks for a further 5 days (Gordon-
Keylock et al., 2010; Krassowska et al., 2006). To isolate
FLK1+ cells, EBs were maintained in suspension cultures
(3 × 104 cells/ml in ES medium without LIF) in sterile
bacteriological grade Petri dishes for 4 days. EBs were then
dissociated and incubated with biotin-conjugated anti-mouse-
FLK1 antibody (eBioscience) then fractionated using anti-biotin
MicroBeads (Miltenyi Biotec) according to the manufacturer's
protocol. Isolated FLK-1+ cells (4 × 104/cm2) were plated
directly onto irradiated stromal cells in EBD medium (IMDM
supplemented with 15% FCS, 200 μg/mL iron-saturated trans-
ferrin (Roche), 4.5 mM monothiolglycerol (Sigma), 50 μg/mL
ascorbic acid (Sigma), penicillin/streptomycin (Gibco), and
2 mM glutamine) for further differentiation.
Cells were assayed for haematopoietic colony (CFU-Cs
(Colony Forming Unit-culture)) formation after harvesting
and dissociating with trypsin solution to generate a single
cell suspension. 5 × 104 or 1 × 105 cells were then seeded
into methylcellulose culture medium (MethoCult® M3434)
and all the total number of colonies counted were normalised
and expressed as CFU-C per 105 cells in all figures. The
1278 C. Huang et al.colonies were classified based on the morphology by light
microscopy and scored between day 7 to day 12. Defined
concentrations of 4-hydroxy tamoxifen (4-OHT) (H6278, http://
www.sigmaaldrich.com) dissolved in ethanol were added to
co-cultures or methylcellulose cultures when required.ESC were distinguished from stromal cells either by GFP
expression in ESCs or by staining stromal cells with Vybrant DiD
(Invitrogen) and the percentage of ESC-derived cells in
co-cultures was determined using the BD™ FACSCalibur or BD™
LSRFortessa cell analyzer. The number of colonies derived from
1279Haematopoietic differentiation when Notch activity is enhancedESCwas then calculated by dividing the total number of colonies
scored by the percentage of ESC-derived cells in the sample.
Flow cytometry analysis and fluorescent-activated
cell sorting (FACS)
Flow cytometry analysis was carried out on BD™ FACSCalibur
or BD™ LSRFortessa cell analyzer and data analysed using
FACSDiva or Flowjo. Cell sorting was performed on BD™
FACSAria II cell sorter or BD™ FACS Jazz. Cells were incubated
with optimal concentrations of antibodies as described
(Gordon-Keylock et al., 2010). Directly conjugated antibodies
against cKit, CD45 and CD41 were purchased from eBioscience.
Human-CD2+ (hCD2) cells were stained with anti-hCD2-PE (BD
Bioscience). Stromal cells were stained with anti-Jagged 1
(R&D) and anti-Delta-like 1 (Abcam) followed by secondary
conjugated antibody staining.
Quantitative reverse transcription (RT)-polymerase
chain reaction (PCR)
Total RNA was extracted using RNeasy Mini Kit (Qiagen) and
cDNA prepared by reverse transcription using SuperScript ™
III First-strand Synthesis SuperMix or SuperScript® VILO™
Master (Invitrogen). Quantitative real-time RT-PCR was
performed on an ABI 7500FAST qPCR machine using TaqMan
PCR chemistry or Sybr green under universal conditions
(Applied Biosystems). Samples were analysed in triplicate,
using Hprt (hypoxanthine-guanine phosphoribosyl transfer-
ase) or 18s (18S ribosomal RNA) as the endogenous control.
Relative quantitation was calculated using the ΔΔCT method in
ABI SDS1.4 software and data are presented as fold change in
gene expression relative to an internal calibrator. Primers and
probes information are listed in Supplemental Table 1.
Luciferase assay
2 × 10-5 cells were plated into 24 well plate in ESC culture
medium. 24 h later cells were co-transfected with 0.75 μg
12xRBPJκ-luciferase reporter plasmid plus 15 ng of internal
control plasmid (pEFBos/renilla luciferase) in the presence
or absence of 4-OHT (1 μM). As a positive control, 0.25 μg of
pCAG-NotchIC plasmid was co-transfected. As a negative
control, 0.75 μg pGL3 control plasmid plus 15 ng of internal
control plasmid were transfected. Cells were collected 48 h
later and analysed with Promega Dual Luciferase Kit (Promega)Figure 4 Haematopoietic differentiation of FLK1+ cells is inhibit
strategy: FLK1+ cells were sorted from day 4 EBs, co-cultured on A
analysed by flow cytometry or fractioned by FACS based on hCD2 ex
methylcellulose assay (in the presence or absence of 4-OHT) and
co-expressing CD41 and cKit and cells expressing the pan-haema
(i.e. NotchIC-expressing) cells compared to hCD2− cells. Representa
the data from 6 to 7 independent experiments: error bars, SEM.
(*p b 0.05). C–F. The number of CFU-M and CFU-GM produced from h
to the hCD2− population when 4-OHT was present in the co-culture
the numbers of erythroid (BFU-E and CFU-E produced from CD2+ and
CFU-M and CFU-GM colonies was observed when 4-OHT was only ad
cells (E, F). All CFU-C results are expressed as number per 105 cell
P values were calculated using the Mann–Whitney test (*p b 0.01).according to manual instruction. Ratios of firefly luciferase
reporter/renilla luciferase control were compared to the
reference sample to give a fold change.
Western blotting
Cells were harvested and lysed with cold RIPA buffer
(ThermoScientific) in the presence of 1% protease inhibitor
(Sigma). Protein samples were separated using NuPAGE®
SDS-PAGE Gel System (Invitrogen) with NuPAGE® 4–12% Bis
Tris Gels then semidry electro-transferred onto nitrocellu-
lose membranes. Membranes were probed with anti-GFP or
control anti-STAT3 antibodies (Cell signalling technology)
then incubated with Horseradish-conjugated anti-rabbit
antibody (Santa Cruz) before adding ECL substrate and
autoradiography.
Immunochemistry
Stromal cells were grown on glass coverslips in 24 well plates
coated with 0.1% gelatin and irradiated when getting around
100% confluent then further cultured for another 24 h. Cells
were fixed with 4% PFA (Sigma) and blocked in 5% donkey
serum (Sigma) in PBST (0.001% Triton X-100 in PBS) then
incubated with rat anti-Delta-like 4 (R&D) at 4 °C overnight
followed by an incubation of FITC conjugated anti-rat
antibody together with 1 μg/ml DAPI (Invitrogen). Cover-
slips were mounted with Prolong Gold mounting medium
(Invitrogen).
Results
Co-culture on AM14 stromal cells does not affect
the production of FLK1+ cells but promotes their
subsequent haematopoietic differentiation
Our previous work demonstrated that AM stromal cell lines
derived from the AGM region provide a haematopoietic
promoting microenvironment during the differentiation of
ESCs and, using the Bry-GFP reporter cell line and one of AM
stromal cell lines-AM14.1C4, we showed that the promoting
effect acted after the formation of mesoderm (Gordon-Keylock
et al., 2010; Krassowska et al., 2006). To further define the
haematopoietic promoting activity of this co-culture system we
assessed the expression of FLK1, a marker for a mesodermaled in the presence of NotchIC. A. Schematic of experimental
M14 stromal cells in the presence 4-OHT for a further 2 days,
pression and subsequently analysed by flow cytometry, in vitro
qRT-PCR. B. The percentage of haematopoietic progenitors
topoietic marker, CD45 were reduced significantly in hCD2+
tive flow cytometry data is shown and quantification represents
P values were calculated using Wilcoxon matched pair tests.
CD2+ (NotchIC expressing) cells was significantly lower compared
for 2 days (C). In contrast there was no significant difference in
CD2− population (D). No significant reduction in the number of
ded in methylcellulose assay stage from both NIC-C5 and E14IV
s. Data represent 3 independent experiments; error bars, SEM.
1280 C. Huang et al.progenitors that have the potential to form cardiac, endothelial
and haematopoietic lineages (Fehling et al., 2003). We co-
cultured differentiating EBs on AM14 (AM14.1C4) stromal cells,
sorted ESC-derived cells from contaminating stromal cells then
analysed the proportion of FLK1+ cells by flow cytometry and
the level of expression of Flk1 mRNA by qRT-PCR analysis
(Fig. 1A). The kinetics of FLK1 expression was not significantly
altered by co-culture on stromal cells suggesting that they must
exert their haematopoietic promoting effects after the emer-
gence of cells that express this receptor (Figs. 1B, C). We noted
that the production of FLK1+ cells and CFU-Cs after co-
culture with the AM14 stromal cell line was slightly higher
(although not statistically significant) to the commonly
used bone marrow-derived OP9 cell line (Supplementary
Figs. 1A–C). In contrast co-culture of differentiating ESC on
stromal cell lines (UG26) from the urogenital ridge (UG)
region of the AGM appeared to have an inhibitory effect on
the production of Flk1+ cells (Supplementary Figs. 1A, B).
We next tested whether FLK1+ cells, produced in the
absence of stromal cells, could respond directly to the AM14
stromal cells. We isolated FLK1+ cells that were generated in
differentiating EBs at day 4 which was the peak time point of
their production (data not shown). Sorted FLK1+ cells were
co-cultured on irradiated AM14 stromal cells for a further
two days then their haematopoietic colony forming ability
was assessed (Fig. 1D). Co-culture with AM14 stromal cells
significantly increased the number of CFUs derived from
FLK1+ cells by approximately threefold compared to the
gelatin control in two independent ESC lines (Fig. 1E). The
increase in haematopoietic progenitor number after AM14
co-culture was confirmed by the percentage and absolute
numbers of cells co-expressing CD41 and cKit which have been
reported to mark definitive ESC-derived haematopoietic pro-
genitors (Mikkola et al., 2003) (Fig. 1F). Taken together these
data demonstrate that the AM14 stromal cells did not affect the
emergence of FLK1+ cells but could further enhance their
haematopoietic development and/or survival. We believe that
this model system provides a simple in vitro model system to
dissect the role of specific signalling pathways on the
haematopoietic development within the AGM microenviron-
ment. Our previous work had demonstrated that cell–cell
contact was required (Gordon-Keylock et al., 2010) and this led
us to hypothesise that theNotch pathway could be playing a role
at this stage in haematopoietic differentiation as previously
suggested by others (Kumano et al., 2003; Robert-Moreno et al.,
2005, 2008). To test this hypothesis we first assessed the
expression of Notch ligands in AGM stromal cell lines then used
inducible gain-and loss-of-function strategies to manipulate of
Notch activity within FLK1+ mesoderm progenitor cells.Profile of Notch ligand expression in AM14 stromal cell
line is distinct from OP9
We analysed the expression of the Notch ligands, Jagged 1,
Jagged 2, delta-like 1(Dll1) and delta-like 4 (Dll4) in the
AM14 stromal cell line compared to the commonly used bone
marrow derived OP9 cell line (Fig. 2). OP9 cells expressed
significantly higher levels of Jagged 1 but lower levels of
Jagged 2 compared to the AM14 stromal cell line as assessed
by q-RT-PCR analysis and flow cytometry (Figs. 2A, B). There
was no significant difference in the expression of Dll1 andDll4 between the two cell lines (Figs. 2A–C). These data
suggest that stromal cell lines derived from different
haematopoietic sites have distinct Notch ligand profiles
and are thus likely to exert their enhancing effects by
distinct mechanisms.Ectopic NotchIC abrogates haematopoietic
differentiation of FLK1+ cells
We tested whether enhancing Notch activity using a
gain-of-function strategy would subsequently affect the
differentiation potential of FLK1+ cells (Fig. 3A). We used a
4-OHT inducible ES cell line (NIC-C5) which expresses
NotchIC-IRES-hCD2 upon the addition of 4-OHT (Lowell et
al., 2006). 4OHT induces the translocation of Cre-ERT2 to the
nucleus where it mediates recombination between loxP sites
in the Rosa26 locus resulting in the expression of NotchIC and
hCD2 (Supplementary Fig. 2A). hCD2 therefore marks all
cells that express NotchIC providing a convenient marker for
recombination efficiency and for the isolation of NotchIC+
and NotchIC− cell populations (Lowell et al., 2006). We
confirmed an enhancement of Notch activity upon 4-OHT
induction using a luciferase assay for transcription activity
and qRT-PCR for Notch target gene expression (Supplemen-
tary Figs. 2B, C). We differentiated ESCs in EBs for four days,
fractionated FLK1+ cells by MACS and cultured these on AM14
stromal cells for an additional two days in the presence or
absence of 4-OHT. There was no significant difference in
total cell numbers in the presence and absence of tamoxifen
(Supplementary Fig. 2D). Cells were harvested and analysed
by qRT-PCR, flow cytometry and CFU-C assays (Fig. 3A). The
frequency of CD41+cKit+ cells was slightly lower when NIC-C5
ESCs, but not control E14IV ESCs, were treated with 4-OHT
(Fig. 3B) suggesting that high levels of Notch had a slight
inhibitory effect on the differentiation of definitive
haematopoietic progenitors from FLK1+ cells. Induction of
NotchIC by addition of 4-OHT also had an inhibitory effect
on the formation of multi-potent CFU-GEMM, CFU-M and
CFU-GM colonies (Figs. 3C & D). In contrast, induction of
NotchIC had no effect on the production of erythroid
colonies (BFU-E, CFU-E) (Fig. 3E). This suggests that there
is a differential effect of NotchIC on the commitment of
FLK1+ cells to specific haematopoietic lineages in this
system (Figs. 3C–E).
Interpretation of these experiments could be limited by
incomplete Cre-mediated excision that had been calculated
to be approximately 50% (Supplementary Fig. 2E). There-
fore, to further define the effect of NotchIC, we fraction-
ated NotchIC+ and NotchIC− populations from the same
co-culture based on hCD2 expression (Fig. 4A) (Lowell et al.,
2006). Consistent with our analysis of unfractionated cultures,
the frequency of CD41+cKit+ haematopoietic progenitors was
slightly lower in the hCD2+ (NotchIC+) compared to the hCD2−
(NotchIC−) fraction suggesting that activation of Notch inhib-
ited the production of definitive progenitors (Fig. 4B). When
co-cultures were treated with 4-OHT for a longer period of
time (to day 9) the frequency of cells expressing the pan-
haematopoietic marker CD45 was more profoundly reduced in
the hCD2+ compared to hCD2− fraction (Fig. 4B).
The hCD2+ cell population formed significantly less
CFU-GM and CFU-M colonies in methylcellulose compared
1281Haematopoietic differentiation when Notch activity is enhancedto the hCD2− population supporting the notion that Notch
activity was inhibitory to production of myeloid progenitors
(Fig. 4C). In contrast, and again consistent with the results
from unfractionated cultures, there was no significant
difference in the number of erythroid colonies produced
from CD2+ and CD2− cell populations (Fig. 4D). No reduction
in the number of myeloid colonies was observed when 4-OHT
was added to the methylcellulose culture of CD2− cells
indicating that NotchIC abrogated the formation of myeloid
progenitors during co-culture but had no effect on their
subsequent proliferation and differentiation in the colony
assay (Fig. 4E). There was no effect of 4-OHT on the
proliferation of E14IV-derived myeloid cells in methylcellu-
lose assay excluding a toxic effects of 4-OHT (Fig. 4F) (Shi
and Petrie, 2012).
The effect of NotchIC was further assessed by qRT-PCR
of target genes. The Notch downstream gene, Hey1 was
increased 8-fold in the hCD2+ fraction compared to hCD2−
fraction. However there was no significant effect on the
expression of Gata2 and only a modest effect on the
expression of Runx1 that are reported to be downstream of
the NotchIC signalling pathway and to regulate definitiveFigure 5 A. The level of expression ofHey1was significantly higher in h
was a modest, but significantly higher level of expression of Runx1 but th
level of expression of the haematopoietic-related genes (Scl, Lmo2,
(NotchIC+) compared to CD2− cells. C. There was no significant differen
higher level of expression of VE-Cad in CD2+ (NotchIC+) compared to CD
noted a modest increase in Tbx6 but no difference in expression levels o
levels in hCD2+ (NotchIC+) fraction were expressed as fold increase over
endogenous control. Data represented 9 reactions from 3 independent
Mann–Whitney test (*p b 0.05).haematopoiesis in the AGM region (Fig. 5A). A significantly
lower level of expression of haematopoietic marker genes
including Pu1, Gata1, Scl/Lmo2, β-H1 and β-major was
observed in cells with elevated Notch activity (Fig. 5B).
NotchIC had no dramatic effect on the expression levels of
Flk1 or VE-cad indicating that ectopic Notch signalling did not
maintain cells at the haemangioblast cell state (Fig. 5C)).
However we could speculate that the modest, but signifi-
cant increase in both VE-cad and Runx1 might indicate that
the Notch activation favours the transition to haemogenic
endothelium but further experiments are necessary to
prove this hypothesis. There was no significant difference
in the expression of Sox17 that is reported to be a critical
marker to distinguish the AGM-derived from yolk sac derived
haematopoiesis as well as for proliferation of haemogenic
endothelium cells (Irion et al., 2010; Nakajima-Takagi et al.,
2013). We observed a modest increase in the expression
of Tbx6 but not Dll3 that are reported as markers of
paraxial mesoderm. Taken together, our data suggest that
inhibition of haematopoietic differentiation by ectopic
NotchIC occurs after haemogenic endothelium formation
and proliferation.CD2+ (i.e. NotchIC-expressing cells) compared to hCD2− cells. There
ere was no significant difference in the expression of Gata2. B. The
PU.1, Gata1, β-H1 and β-major) was significantly lower in CD2+
ce in the level of expression of Flk1 and a modest but significantly
2− cells. Of genes associated with non-haematopoietic lineages, we
f Dll3 or Sox17 between CD2+ (NotchIC+) and CD2− cells. Expression
the related to hCD2− fraction (assigned as 1). HPRT was used as the
experiments; error bars, SEM. P values were calculated using the
1282 C. Huang et al.iDML can inhibit exogenous and endogenous Notch
activity but has no effect on haematopoietic
differentiation of FLK1+ cellsWe also used a dominant negative approach to regulate
Notch activity in our FLK1+/AM14 stromal co-culture system.Mastermind-like (MAML) proteins are critical transcription-
al co-activators for Notch signalling and the truncated,
dominant-negative form (DNMAML) can act as a potent
inhibitor of the pathway (Weng et al., 2003). DNMAML
encodes amino acids 13 to 74 of MAML providing the binding
site for NotchIC but this truncated protein cannot recruit
other co-activators such as p300 to form the fully functional
Figure 7 Notch activity is dynamic, reducing to basal levels as
FLK1+ cells differentiate into haematopoietic progenitors. Ectopic
NotchIC has an inhibitory effect on the production of multi-lineage
and myeloid progenitors with a more severe inhibitor effect
when endogenous Notch activity is at its lowest basal level which is
most likely to occur after hemogenic endothelium formation.
No significant effect was observed on the subsequent erythroid
differentiation.
1283Haematopoietic differentiation when Notch activity is enhancedRBP-Jk activator complex. It has been used in a number of
studies to assess the role of Notch signalling during haema-
topoietic differentiation (Maillard et al., 2008; Mercher et
al., 2008; Yu et al., 2008). We targeted a cDNA fragment
encoding DNMAML fused to EGFP into the HPRT locus of the
A2loxCre ESC line resulting in its regulation by a tet-responsive
promoter (Iacovino et al., 2011) (Fig. 6A). DNMAML-EGFP
expression was induced upon addition of doxycycline (dox)
and detected by Western blotting and flow cytometry in
ESC clones with the correctly targeted integration (iDML)
(Figs. 6B, C). To assess whether DML could inhibit endogenous
Notch activity during differentiation, we demonstrated that
the expression of the Notch downstream target, Hey1 in
differentiating EBs was significantly reduced upon addition of
dox (Fig. 6D). We then induced the expression of DNMAML in
isolated, FLK1+ cells co-cultured on AGM stromal cells (Fig. 6E).
The number of CFC's produced was not significantly affected by
expression of DNMAML (Fig. 6F). We also demonstrated that
there was no significant difference in the numbers of CFU-Cs
produced by FLK1+ cells co-cultured on AM stromal cells in the
presence of the Notch inhibitor DAPT (Supplementary Fig. 3).Figure 6 iDML can inhibit exogenous and endogenous Notch activity
A. Scheme of the dox inducible iDML-EGFP ESC line where the TRE-DML-E
B. Expression of DNMAML-EGFP induced by 0.5 μg/ml dox was confirmed
endogenous control. Cos7 cells were transfected with pEGFP-DML-N3
confirmed by flow cytometry. Red line represents untreated and b
demonstrating a reduction in Hey expression in dox-treated iDML.1 but n
from 2 independent experiments; error bars, SEM. E. Schematic of ex
parental ESC lines or ESC lines carrying the inducible DML1 or EGFP, co-cu
further 2 days then analysed by in vitro colony forming assays and qRT
significantly altered upon induction of DML. Fold change in colony numbe
co-culture. G. Notch activity in FLK1+ derived cells decreased to barely d
Hey1 in three independent cell lines (iDML.1, iEGFP.1 and NIC-C5). P-valThere was a significant reduction in endogenous Notch
activity (as assessed by Hey1 expression) in FLK1+ cells at
day 6 compared to day 4 in three independent ESC lines
(Fig. 6G). This suggests that Notch activity drops to a basal
level at this stage of the differentiation process. Taken
together, these results indicate that Notch activity in FLK1+
derived cells in this system is dynamic, reducing to basal
levels as they differentiate and as a result there are no
functional consequences of our dominant negative strategy
nor pharmacological Notch inhibition. However we cannot
exclude the possibility that the reduction in Hey expression
is due to a lack of endothelial cells that our culture may not
support.
To our knowledge this is the first time that an inducible
DNMAML has been used to modulate Notch activity in
differentiating ESCs and represents a powerful approach to
assess the role of the Notch pathway in a wide range of
developmental pathways.Discussion
We describe the co-culture of ESC-derived FLK1+ cells on
AGM-stroma that provides a simple model to study the
molecular pathways involved in haematopoietic development
in the AGM microenvironment. We demonstrate that the AGM
derived stromal cell line promotes the differentiation of FLK1+
mesodermprogenitor cells into haematopoietic lineages andwe
have used our system to assess the role of the Notch pathway at
this point in the differentiation of a defined subpopulation of
cells. AM14 stromal cells have a distinct Notch ligand profile
compared to OP9 with the expression of Jagged 1 being
significantly lower and the expression of Jagged 2 being higher
than OP9. This indicates that the different microenvironments
have distinct Notch ligand activity. Our goal in this study was
to study the role of Notch signalling within the AGM-type
microenvironment. We noted that Notch signalling is dynamic
during the co-culture with the lowest level being associated
with the time of haematopoietic progenitor production. Further
reduction of this low level had no functional consequences with
the haematopoietic differentiation of FLK1+ cells being unaf-
fected by the overexpression of dominant negative MAML. In
contrast, activation of the Notch pathway by NotchIC inhibited
the subsequent production of haematopoietic progenitors from
FLK1+ cells as assessed by CFU-C formation and the expression
of haematopoietic cell surface markers and transcription
factors. Our Cre-mediated recombination strategy, whereby
NotchIC-expressing cells were marked with the hCD2 receptor,but has no effect on haematopoeitic differentiation of FLK1+ cells.
GFP is targeted to the HPRT locus and the rtTA to the ROSA26 locus.
by western blot using an EGFP antibody. β-tubulin was used as the
plasmid as the positive control. C. Expression of DML-EGFP was
lue line represents ESCs treated with dox. D. qRT-PCR analysis
ot the control parental or iEGFP ESCs. Data represents 3–6 reactions
perimental strategy: FLK1+ cells were sorted from differentiating
ltured on AM14 stromal cells in the presence or absence of dox for a
-PCR. F. The number of CFU-C generated from FLK1+ cells was not
r was calculated by normalizing number of colonies in +Dox to −Dox
etectable levels by day 6 of co-culture as assessed by expression of
ues calculated using Mann–Whitney test (**p b 0.01, *** p b 0.001).
1284 C. Huang et al.has been a powerful approach because it has enabled us to
directly compare FLK1+ cells that express exogenous NotchIC
with control, FLK1+ NotchIC− cells from the same culture. Thus
we overcome some of the problems that have been associated
with the interpretation of data derived from complex hetero-
geneous cell populations that has resulted in confusing and
sometimes contradictory reports in the literature (Bigas and
Espinosa, 2012). At this stage during haematopoietic differen-
tiation the FLK1+ cell population includes progenitors for a
number of mesodermal lineages including endothelial and
cardiac cells and NotchIC could be acting via interactions
between these cell types.Inhibitory effects of ectopic NotchIC on FLK1+ derived
haematopoiesis
Ectopic Notch-IC expression inhibited the production of
haematopoietic progenitors from FLK1+ cells and this is in
keeping with our hypothesis that the level of Notch activity
must be below a specific threshold for haematopoietic
commitment. We noted that the severity of inhibition
negatively correlated with the level of endogenous Notch
activity: myeloid colony production was inhibited to a greater
extent by Notch IC compared to the modest inhibitory effect on
the production of CD41+ckit+ cells (Fig. 7).
Our finding that myeloid progenitor formation is inhibited
by expression of NotchIC is consistent with some of the
previous studies that used complex mixtures of cells. For
example, ectopic NotchIC expression suppressed the pro-
duction of myeloid progenitors and the expression of critical
myeloid transcription factors and activation of Notch sig-
nalling by Dll1 resulted in apoptosis of GMPs (Klinakis et
al., 2011). The inhibition of myeloid progenitor production
by Notch signalling in our experiments is also supported by
a study demonstrating reduction of myeloid progenitor
formation by Dll1 while maturation of myeloid lineages was
unaffected (de Pooter et al., 2006). We noted that ectopic
NotchIC inhibited myeloid differentiation by abrogating
myeloid progenitor formation but not their subsequent
proliferation and differentiation possibly via inhibiting PU.1
expression. A similar inhibitory effect of NotchIC on haema-
topoietic differentiation from ESCs co-cultured on OP9
stroma cells has been reported, although in that study it
was suggested that NotchIC abrogated myeloid progenitors
proliferation and accelerated their maturation via up-
regulation of PU.1 expression (Schroeder and Just, 2000;
Schroeder et al., 2003b, 2006). PU.1 is involved at several
stages of haematopoietic differentiation and it is possible
that it responds differently to ectopic NotchIC at different
stages. Interestingly, RBPJk null ESCs appeared to have reduced
ability of form haematopoietic colonies but this phenotype was
not “rescued” by expression of RBPJ K and it was therefore
concluded to be a result of clonal variation (Schroeder et al.,
2003a). This further highlights the power of the inducible and
trackable genetic system that we have used.
Interestingly there was no effect of NotchIC on the
production of erythroid colonies indicating that some level
of Notch activity is tolerated by these progenitors. Further
work is required to determine whether our system generates
primitive or definitive erythropoiesis but it is tempting to
speculate that the erythroid progenitors generated in ourcultures represent the definitive erythropoiesis. This is
because our data are consistent with a study demonstrating
that ectopic NotchIC had no effect on the production of
definitive erythroid progenitors produced from ESC-derived
FLK1+ cells after re-aggregation in the presence of cytokines
(Cheng et al., 2008). Although there are numerous reports of
an inhibitory effect of Notch signalling on primitive erythroid
differentiation and maturation (Elagib et al., 2004; Ishiko,
2004; Lam, 2000; Maeda et al., 2009; Okuhashi et al., 2010;
Robert-Moreno et al., 2007; Ross et al., 2012; Tachikawa et
al., 2006) there are also opposing results suggesting that
Notch signalling promotes this process (Henning et al., 2007;
Sugimoto et al., 2006). An explanation for these differences
is likely due to level of expression of exogenous NotchIC,
differences in the experimental systems used and thus the
complexity of other signalling pathways that are likely to be
interacting with, and modulating, Notch signalling. The fact
that activation of Notch signalling is able to rescue defects in
haematopoietic progenitor production observed in the ab-
sence of Hedgehog signalling highlights the complex nature
of this process and further emphasizes the importance of
studying these interactions in defined cell populations (Kim et
al., 2013).
Activation of NotchIC did not alter the expression of Gata2
and had only minor effect of the expression of Runx1 that have
been reported as downstream target genes of Notch signalling
and are critical for long-term and definitive haematopoiesis
(Burns, 2005; Nakagawa et al., 2006; Nottingham et al., 2007;
Robert-Moreno et al., 2005, 2008). This could be explained by
the fact that moderate overexpression level of NotchIC in our
system is not sufficient and/or requires co-factors to activate
Gata2. The fact that NotchIC inhibited the expression of other
haematopoietic-related genes such as Scl/Lmo2, Gata1, PU.1
β-globin and the production of CFU-Cs and definitive progen-
itors (defined as CD41+cKit+) suggests that both primitive and
definitive haematopoietic programmes are affected in this
culture system.Effect of DNMAML in regulating Notch
signalling pathway
Notch activity decreased significantly during the co-culture
of FLK1+ cells on AM stromal cells and the introduction of
DNMAML1 at this point in the differentiation system had no
functional consequence. This result confirms other findings
where DNMAML has been shown to have minimal effects in
systems where Notch activity is low. For example, one study
demonstrated that bone marrow derived LSK progenitors
were exposed to a lower level of Notch signalling compared to
more committed progenitors and that induction of DNMAML1
did not abrogate the expression of Hes1, Dtx1 or Runx1
in this context. However after exposure to the exogenous
Delta-like 1 ligand, the expression of Hes1 and Dtx1
expression was enhanced and this enhanced expression
could then be inhibited by DNMAML1 (Maillard et al., 2008).
Similarly, DNMAML1 prevented megakaryocyte differentia-
tion from megakaryocyte-erythroid progenitors possessing
higher Notch activity compared to multi-lineage progeni-
tors (Mercher et al., 2008). Thus, DNMAML1 can only have
functional consequences in systems where there is a high
level of Notch activity. Our data suggest that haematopoietic
1285Haematopoietic differentiation when Notch activity is enhancedcommitment of FLK1+ cells in the AM microenvironment
requires Notch activity to be at a basal level and is
therefore consistent with several studies that have dem-
onstrated an inhibitory effect of Notch signalling on
haematopoietic differentiation and lineage commitment
from progenitors (Bigas et al., 1998; Li et al., 1998; Milner
et al., 1996).Haematopoietic enhancing effect of AM derived
stromal cells
The AM14 stromal cell line used in our study was derived from
the dorsal aorta and surrounding mesenchymal area of the AGM
region. During haematopoietic ontogeny the underlying mesen-
chyme has been suggested as a potential niche for the further
differentiation of the haemangioblast into pre-HSCs, the
formation of haemogenic endothelium and/or the maturation
of pre-HSCs (Costa et al., 2012). Our co-culture system might
therefore provide an in vitro model of this developmental
process. The AM14 stromal cell line expresses SCF, G-CSF aswell
as chordin-like protein that are known to be expressed in
mesenchymal cells (Charbord et al., 2002; Oostendorp et al.,
2002b) and therefore have the potential to promote the survival
and self-renewal ability of haematopoietic progenitors (Durand
et al., 2007; Jackson et al., 2012).Conclusion
In summary, using an inducible genetic system which has
allowed us to compare NotchIC+ and NotchIC− cells from the
same culture we have resolved some of the discrepancies
in the literature about the role of this signalling pathway
during haematopoietic differentiation. We conclude that
within the AGM microenvironment the production of haema-
topoietic cells from FLK1+ progenitors is optimal when
Notch signalling is below a specific threshold. The oppor-
tunity to modulate Notch signalling via its interaction with
other signalling pathways such as Wnt and Hedgehog could
lead to new strategies for regenerative medicine and the
production of haematopoietic cells from pluripotent cells
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